BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)

Last updated: March 15, 2025
Sponsor: Boston Scientific Corporation
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cardiac Disease

Treatment

Implant

Electrophysiologic procedure

Clinical Study ID

NCT04823663
C2157
  • All Genders

Study Summary

SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Subject is willing and capable of providing informed consent and/or to give approvalto collect/store/process personal health information by the sponsor or suchconsent/approval is provided by a legally designated representative, if required bylocal law or regulation.

  2. Subject is (one criterion must be fulfilled) a. prospectively scheduled for aprocedure involving i. use of a BSC EP Ablation product or BSC Capital Equipmentproduct or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reportingof all past visits is available and complete including i. the procedure where beingdiagnosed or treated with at least 3 separate BSC EP Ablation products/components orBSC Capital Equipment products/components or ii. the BSC CRM product implant.

Exclusion

Exclusion Criteria:

  1. Subject is foreseen not to be followed at the enrolling center for at least 1 yearafter an implant procedure (CRM) or at least 1 month (EP).

  2. Subject is receiving diagnosis or therapy by means of any product, that is notapproved for commercial use at the time of implant/procedure.

Study Design

Total Participants: 12500
Treatment Group(s): 2
Primary Treatment: Implant
Phase:
Study Start date:
March 31, 2021
Estimated Completion Date:
December 31, 2030

Study Description

SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.

SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.

SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.

The expected duration of SOCRATES participation for a subject is dependent on

  • the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or

  • the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.

For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.

Connect with a study center

  • Universitair Ziekenhuis Brussel

    Jette, 1090
    Belgium

    Active - Recruiting

  • CHU UCL Namur - Site Godinne

    Yvoir, 5530
    Belgium

    Active - Recruiting

  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec

    Quebec City, Quebec G1V 4G5
    Canada

    Active - Recruiting

  • CHRU de Brest, Hôpital de la Cavale Blanche

    Brest, 29200
    France

    Active - Recruiting

  • CHRU de Clermont-Ferrand

    Clermont-Ferrand, 63000
    France

    Active - Recruiting

  • Hopital Saint Philibert

    Lomme, 59462
    France

    Active - Recruiting

  • CHG de Pau

    Pau,
    France

    Active - Recruiting

  • CHU de Saint-Etienne

    Saint-Étienne, 42055
    France

    Active - Recruiting

  • Unfallkrankenhaus Berlin Marzahn

    Berlin, 12687
    Germany

    Active - Recruiting

  • Augusta Kranken Anstalt GmbH

    Bochum, 44791
    Germany

    Active - Recruiting

  • General Hospital of Athens "G. Gennimatas"

    Athens, 11527
    Greece

    Completed

  • Onassis Cardiac Surgery Center

    Athens, 17674
    Greece

    Active - Recruiting

  • Mater Private Hospital

    Dublin, D07 WKW8
    Ireland

    Active - Recruiting

  • Sheba Medical Center

    Ramat-Gan, 52621
    Israel

    Active - Recruiting

  • Policlinico di Modena

    Modena, 41124
    Italy

    Active - Recruiting

  • Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina

    Roma, 00186
    Italy

    Active - Recruiting

  • Policlinico Casilino

    Roma, 00169
    Italy

    Active - Recruiting

  • Policlinico Universitario Agostino Gemelli

    Roma, 00168
    Italy

    Active - Recruiting

  • Hospital Universitario de Canarias

    La Laguna, 38320
    Spain

    Active - Recruiting

  • Hospital Clinico San Carlos

    Madrid, 28040
    Spain

    Active - Recruiting

  • Hospital Nuestra Señora de La Candelaria

    Santa Cruz De Tenerife, 38010
    Spain

    Active - Recruiting

  • Hospital Universitario Miguel Servet

    Zaragoza, 50009
    Spain

    Active - Recruiting

  • St. Bartholomew's Hospital

    London, EC1A 7BE
    United Kingdom

    Active - Recruiting

  • Manchester Heart Center

    Manchester, M13 9WL
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.